Priming with Toll-like receptor 3 agonist or interferon-gamma enhances the therapeutic effects of human mesenchymal stem cells in a murine model of atopic dermatitis

BACKGROUND: Atopic dermatitis (AD) is a chronic and relapsing inflammatory skin disease. Great efforts have been recently made to treat AD using mesenchymal stem cells (MSCs), which have immunomodulatory functions. However, the immunomodulatory effects of MSCs need to be enhanced for clinical applic...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Arum, Park, Hyojung, Yoon, Jisun, Kang, Dayeon, Kang, Myoung-Hee, Park, Y-Y, Suh, Nayoung, Yu, Jinho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387524/
https://www.ncbi.nlm.nih.gov/pubmed/30795812
http://dx.doi.org/10.1186/s13287-019-1164-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387524/
https://www.ncbi.nlm.nih.gov/pubmed/30795812
http://dx.doi.org/10.1186/s13287-019-1164-6

Ejemplares similares